Mycophenolic acid pharmacokinetics in paediatric liver transplant recipients.

被引：0
|
作者：
Aw, MM
Brown, N
Tredger, M
Mieli-Vergani, G
Dhawan, A
机构：
[1] Kings Coll London Hosp, Paediat Liver Svc, London, England
[2] Kings Coll London Hosp, Inst Liver Studies, London SE5 8RX, England
[3] GKT Sch Med, Inst Liver Studies, London, England
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
481
引用
收藏
页码：292A / 292A
页数：1
相关论文
共 50 条
  • [31] SUBJECTIVE EXPERIENCES OF PARENT DONORS OF PAEDIATRIC LIVER TRANSPLANT RECIPIENTS.
    Tan, A. W. L.
    Yuen, W. Y.
    Karthik, S. V.
    Law, J. H.
    Kow, W. C. A.
    Aw, M.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 16 - 16
  • [32] Population Pharmacokinetics of Mycophenolic Acid in Liver Transplant Recipients and a Comparison of FOCE and EM Estimation Methods
    Hu, H.
    Chen, B.
    Wang, X.
    Feng, M. R.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S93 - S93
  • [33] PIPERACILIN PHARMACOKINETICS AND TARGET ATTAINMENT IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS.
    Morales Junior, R.
    Juodinis, V.
    Romano, P.
    Duarte, N.
    Souza, D.
    Santos, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S117 - S118
  • [34] Establishing a limited sampling strategy for mycophenolic acid monitoring in lung transplant recipients.
    Partovi, N
    Ting, LSL
    Ensom, MHH
    Riggs, W
    Levy, RD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 346 - 346
  • [35] Pharmacokinetics and protein binding of mycophenolic acid in stable lung transplant recipients
    Ensom, MHH
    Partovi, N
    Decarie, D
    Dumont, RJ
    Fradet, G
    Levy, RD
    THERAPEUTIC DRUG MONITORING, 2002, 24 (02) : 310 - 314
  • [36] Population pharmacokinetics of mycophenolic acid and its determinants in renal transplant recipients
    van Hest, RM
    van Gelder, T
    Vulto, AG
    Mathôt, RAA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (01) : 106 - 107
  • [37] Clinical Significance of Mycophenolic Acid Therapeutic Drug Monitoring in Kidney Transplant Recipients.
    Kim, C. -D.
    Cho, J. -H.
    Kim, K.
    Kim, M.
    Do, W.
    Yang, Y.
    Yim, T.
    Hwang, I.
    Lee, J. -H.
    Jung, H. -Y.
    Choi, J. -Y.
    Park, S. -H.
    Kim, Y. -L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 784 - 784
  • [38] Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients
    Wang, C. X.
    Meng, F. H.
    Chen, L. Z.
    Ren, B.
    Li, S. X.
    Fei, J. G.
    Qiu, J.
    Deng, S. X.
    Li, J.
    Chen, S. Y.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (05) : 1392 - 1395
  • [39] Conversion from Sandimmun to Neoral in stable paediatric liver transplant recipients.
    vanMourik, IDM
    Nagle, A
    Kelly, DA
    HEPATOLOGY, 1997, 26 (04) : 432 - 432
  • [40] Concentration of total mycophenolic acid (MPA), mycophenolic acid glucuronide (MPAG) and unbound MPA in diabetic kidney transplant recipients.
    Akhlaghi, F
    Patel, CG
    Zuinga, P
    Lin, S
    Yango, A
    Gohh, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 232 - 232
12345